abstract |
The present invention relates to a pharmaceutical composition comprising a conjugate comprising a bacterial superantigen and an antibody portion and a method of use. In particular, bacterial superantigens have been modified to have reduced serum reactivity while maintaining activity. n n Bacterial Superantigens, Antibody Portions, Serum Reactivity, Conjugates |